APVO - Aptevo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

APVO is currently covered by 1 analysts with an average price target of $16.51. This is a potential upside of $16.23 (5796.43%) from yesterday's end of day stock price of $0.28.

Aptevo Therapeutics's activity chart (see below) currently has 12 price targets and 13 ratings on display. The stock rating distribution of APVO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 10% with an average time for these price targets to be met of 65.5 days.

Highest price target for APVO is $5, Lowest price target is $4, average price target is $16.51.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 12-Aug-2022. First documented stock forecast 05-Oct-2017.

Best performing analysts who are covering APVO - Aptevo Therapeutics:

Edward Tenthoff Jonathan Aschoff

Currently out of the existing stock ratings of APVO, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$13

$11.97 (1162.14%)

$20

2 years 3 months 17 days ago
(12-Aug-2022)

2/10 (20%)

$8.58 (194.12%)

131

Buy

$50

3 years 17 days ago
(12-Nov-2021)

0/2 (0%)

$23.88 (91.42%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is APVO (Aptevo Therapeutics) average time for price targets to be met?

On average it took 65.5 days on average for the stock forecasts to be realized with a an average price target met ratio 10

Which analyst has the current highest performing score on APVO (Aptevo Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on APVO (Aptevo Therapeutics) with a proven track record?

JONATHAN ASCHOFF

Which analyst has the most public recommendations on APVO (Aptevo Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 7 ratings on APVO

Which analyst is the currently most bullish on APVO (Aptevo Therapeutics)?

Edward Tenthoff with highest potential upside - $11.97

Which analyst is the currently most reserved on APVO (Aptevo Therapeutics)?

Jonathan Aschoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?